Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by P.S. Mundi
Umbralisib and Carfilzomib Potently Inhibit Cap Dependent Translation in Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Related publications
Umbralisib: Treatment for a Rare Lymphoma?
Cancer Discovery
Oncology
The Cap-Dependent Translation Apparatus Integrates and Amplifies Cancer Pathways
RNA Biology
Cell Biology
Molecular Biology
A Cyclin-Dependent Kinase, CDK11/p58, Represses Cap-Dependent Translation During Mitosis
Cellular and Molecular Life Sciences
Molecular Neuroscience
Molecular Medicine
Cell Biology
Molecular Biology
Pharmacology
Cellular
Reovirus-Induced Modification of Cap-Dependent Translation in Infected L Cells.
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Cap-Translation Inhibitor, 4egi-1, Restores Sensitivity to ABT-737 Apoptosis Through Cap-Dependent and -Independent Mechanisms in Chronic Lymphocytic Leukemia
Clinical Cancer Research
Cancer Research
Oncology
A Novel Role of 4e-Bp, the Repressor of Cap-Dependent Translation, in Oastoarthrithis
Osteoarthritis and Cartilage
Sports Medicine
Rheumatology
Orthopedics
Biomedical Engineering
Proteomic Analysis of Cap-Dependent Translation Identifies LARP1 as a Key Regulator of 5'TOP mRNA Translation
Genes and Development
Genetics
Developmental Biology
Sorafenib and Carfilzomib Synergistically Inhibit the Proliferation, Survival and Metastasis of Hepatocellular Carcinoma
Molecular Cancer Therapeutics
Cancer Research
Oncology
Fully Human Antagonistic Antibodies Against CCR4 Potently Inhibit Cell Signaling and Chemotaxis
PLoS ONE
Multidisciplinary
